# BioAesthetics Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioaesthetics

- Industry: Materials
- Headquarters: US
- Website: www.bio-aesthetics.com
- Total disclosed funding: $2.5M
- Latest round: Series A (Oct 2, 2020)
- Investors on record: 7

## About

BioAesthetics Corporation is dedicated to developing advanced aesthetic solutions that enhance cosmetic treatments for healthcare providers and patients, focusing on safety and efficacy in skin care technologies.BioAesthetics Corporation, founded in 2015, specializes in innovative aesthetic solutions. The company is headquartered in the US and has conducted 7 deals, with its most recent deal occurring on November 1, 2020, during a Series A round that raised USD 2.50 mn from investors including FemHealth Ventures, IndieBio, NOLA Angel Network, SOSV, and The Launch Place. The CEO, Nicholas Pashos, leads the company, though there is no information on previous ventures or changes in business strategy.BioAesthetics Corporation specializes in innovative aesthetic solutions designed for healthcare providers and patients seeking advanced cosmetic treatments. The company's core product offerings include state-of-the-art skin care technologies and aesthetic procedures that address various skin concerns, enhancing both appearance and self-esteem. These products are typically used in clinical settings by licensed skincare professionals, emphasizing safety and efficacy in their application. BioAesthetics serves a diverse clientele, including dermatologists, plastic surgeons, and medical spas, providing them with the tools necessary to meet the growing demand for non-invasive cosmetic procedures. The company markets its products primarily in North America and select regions in Europe, catering to a demographic that values innovative aesthetic solutions.BioAesthetics Corporation generates revenue through a direct-to-consumer model as well as partnerships with healthcare providers and aesthetic clinics. The company engages in business transactions centered around the sale of its flagship products, which are provided to practitioners who then offer them to their patients. This transactional structure allows for flexibility in pricing plans, where healthcare providers purchase products in bulk at a discounted rate, enabling them to deliver competitive pricing to end-users. Additionally, BioAesthetics may offer training programs and support services as part of their product packages, enhancing the value proposition for their clients. Revenue is driven by the increasing adoption of aesthetic treatments in the healthcare market, reflecting the growing consumer interest in enhancing personal appearance through innovative skincare technologies.In November 2020, BioAesthetics Corporation raised USD 2.50 mn during its Series A funding round. The company plans to leverage these funds to develop new products aimed at expanding its market presence. Future initiatives include the launch of innovative aesthetic solutions targeted for release in 2023, and the company is also looking to penetrate new markets, particularly in Europe and Asia, by 2024. These strategies are designed to meet the rising demand for aesthetic treatments and enhance the overall client experience.

## Funding rounds

- Series A, Oct 2, 2020, $2.5M — SOSV, The Launch Place, IndieBio, NOLA Angel Network, FemHealth Ventures
- Seed, Sep 8, 2017 — Hemi Ventures
- Seed, May 9, 2017 — SOSV, IndieBio, New Orleans BioFund

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed, Series A
- IndieBio (https://capitalatlas.ai/funds/indiebio) — Seed, Series A
- New Orleans BioFund — Seed
- Hemi Ventures (https://capitalatlas.ai/funds/hemi-ventures) — Seed
- The Launch Place — Series A
- NOLA Angel Network — Series A
- FemHealth Ventures (https://capitalatlas.ai/funds/femhealth-ventures) — Series A